Schedule 13G ownership disclosure

Elicio Therapeutics, Inc.

Common Stock, par value $0.01 per share · CUSIP: 28657F103

Event date: 2025-03-31

Filing-level shares
856,382.00
Percent of class
5.4%
  • Actyus Private Equity SGIIC, S.A.

    Shares: 856,382.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050492-25-000001
Form type
SCHEDULE 13G/A
Filer
Actyus Private Equity SGIIC, S.A.
CIK
CIK 2050492
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub